Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer

This publication has 21 references indexed in Scilit:

• 6 Final report of a phase III randomized trial of amifostine as a radioprotectant in head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
  Head & Neck, 1997
• Late effects of radiation therapy in the head and neck region
  International Journal of Radiation Oncology*Biology*Physics, 1995
• A return to “normal eating” after curative treatment for oral cancer. What are the long-term prospects?
  Oral Oncology, 1994
• Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Influence of Late Side-Effects Upon Daily Life After Radiotherapy for Laryngeal and Pharyngeal Cancer
  Acta Oncologica, 1994
• Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
  New England Journal of Medicine, 1993
• Parotid gland function during and following radiotherapy of malignancies in the head and neck
  European Journal Of Cancer, 1992
• Some factors influencing salivary function when treating with radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1981